Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 21, 2021; 27(43): 7433-7445
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7433
Published online Nov 21, 2021. doi: 10.3748/wjg.v27.i43.7433
Figure 1 Possible pathophysiology of irritable bowel syndrome in coronavirus disease 2019 patients.
ACE2: Peptidase angiotensin receptor 2; COVID-19: Coronavirus disease 2019; HPA: Hypothalamus–pituitary–adrenal; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2.
- Citation: Settanni CR, Ianiro G, Ponziani FR, Bibbò S, Segal JP, Cammarota G, Gasbarrini A. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World J Gastroenterol 2021; 27(43): 7433-7445
- URL: https://www.wjgnet.com/1007-9327/full/v27/i43/7433.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i43.7433